Named as a key player in 66 of our reports, across 33 regions and countries.
| Market | Category | World size | Growth |
|---|---|---|---|
| Psychedelic Therapeutics | Pharmaceuticals | In full report | In full report |
| Treatment-Resistant Depression Drugs | Pharmaceuticals | In full report | In full report |
Named as key players in the same markets as Compass Pathways (number of shared markets).
AbbVie Inc.1 shared market
atai Life Sciences1 shared market
Axsome Therapeutics1 shared market
Cybin1 shared market
Johnson & Johnson1 shared market
Lykos Therapeutics1 shared market
MindMed1 shared market
Otsuka Pharmaceutical Co., Ltd.1 shared market